Mapping Thrombosis Serum Markers by 1H-NMR Allied with Machine Learning Tools
Authors:
- Lucas G. MartinsLMLucas G. Martins
- Bruna M. ManziniBMBruna M. Manzini
- Silmara MontalvãoSMSilmara Montalvão
- Millene A. HonoratoMHMillene A. Honorato
- Marina P. ColellaMCMarina P. Colella
- Gabriela G. Y. HayakawaGHGabriela G. Y. Hayakawa
- Erich V. de PaulaEPErich V. de Paula
- Fernanda A. OrsiFOFernanda A. Orsi
- Erik S. BragaEBErik S. Braga
- Nataša AvramovićNANataša Avramović
- Folurunsho Bright OmageFOFolurunsho Bright Omage
- Ljubica TasicLTLjubica Tasic
Open Access
- 13 December 2024
- Vol. 29 (24) , 5895
Abstract
Machine learning and artificial intelligence tools were used to investigate the discriminatory potential of blood serum metabolites for thromboembolism and antiphospholipid syndrome (APS). 1H-NMR-based metabonomics data of the serum samples of patients with arterial or venous thromboembolism (VTE) without APS (n = 32), thrombotic primary APS patients (APS, n = 32), and healthy controls (HCs) (n = 32) were investigated. Unique metabolic profiles between VTE and HCs, APS and HCs, and between VTE and triple-positive APS groups were indicative of the significant alterations in the metabolic pathways of glycolysis, the TCA cycle, lipid metabolism, and branched-chain amino acid (BCAA) metabolism, and pointed to the complex pathogenesis mechanisms of APS and VTE. Histidine, 3-hydroxybutyrate, and threonine were shown to be the top three metabolites with the most substantial impact on model predictions, suggesting that these metabolites play a pivotal role in distinguishing among APS, VTE, and HCs. These metabolites might be potential biomarkers to differentiate APS and VTE patients.Keywords
Funding Information
- São Paulo Research Foundation (Fundação de Amparo à Pesquisa do Estado de São Paulo, FAPESP) (#2016/14172-6, #2014/50867-3, #2018/24069-3, #2021/07212-0, #2023/02691-2)
- FAPESP Postdoctoral (#2016/14172-6, #2014/50867-3, #2018/24069-3, #2021/07212-0, #2023/02691-2)
This publication has 31 references indexed in Scilit:
- Recurrent thrombotic events after disappearance of antiphospholipid autoantibodies: A long-term longitudinal study in patients with antiphospholipid syndromeThrombosis Research, 2023
- Higher lactate and purine metabolite levels in erythrocyte-rich fresh venous thrombus: Potential markers for early deep vein thrombosisThrombosis Research, 2019
- The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate LyaseCell Metabolism, 2018
- Deep Vein Thrombosis Exhibits Characteristic Serum and Vein Wall Metabolic Phenotypes in the Inferior Vena Cava Ligation Mouse ModelEuropean Journal of Vascular and Endovascular Surgery, 2018
- Defective Branched-Chain Amino Acid Catabolism Disrupts Glucose Metabolism and Sensitizes the Heart to Ischemia-Reperfusion InjuryCell Metabolism, 2017
- Antiphospholipid syndrome: A diagnostic challengeMedical Journal Armed Forces India, 2016
- 1D-1H-nuclear magnetic resonance metabolomics reveals age-related changes in metabolites associated with experimental venous thrombosisJournal of Vascular Surgery: Venous and Lymphatic Disorders, 2016
- Antiphospholipid syndromeThe Lancet, 2010
- MetabonomicsNature, 2008
- Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patientsArthritis & Rheumatism, 2002